USAN Council Issues Statement on Aliskiren Fumarate Naming

The USAN Council has assigned the official non-proprietary name 'aliskiren fumarate' through its standard naming process. This establishes the standardized name for regulatory and commercial use in the United States.

Pharmaceutical manufacturers developing or marketing products containing this compound should ensure their labeling, FDA submissions, and prescribing information reflect the USAN Council's assigned name. Drug naming assignments by the USAN Council are adopted for use across pharmaceutical labeling, compendial references, and regulatory filings.